Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Beukes familial hip dysplasia (BFHD) is a primary bone dysplasia, characterized by premature degenerative arthropathy of the hip. The disease presents with hip joint discomfort/pain and gait disturbances that usually develops in childhood and that progresses to severe functional disability and limited mobility by early adulthood. Involvement of the vertebral bodies and other joints is minimal, height is not significantly reduced, and general health is unimpaired. Radiographically, the femoral heads are flattened and irregular and degenerative osteoarthritis develops in the hip joints, as evidenced by the presence of periarticular cysts, sclerosis, and joint space narrowing.
Features include: Hip dysplasia, Avascular necrosis of the capital femoral epiphysis, Broad femoral neck, and Wide proximal femoral metaphysis and 4 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 6 | Avascular necrosis of the capital femoral epiphysis, Broad femoral neck, Wide proximal femoral metaphysis |
UFSP2 function has not been fully characterized.
Hip dysplasia, Beukes type is associated with mutations in the UFSP2 gene on chromosome 4.
Genetic testing for UFSP2 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hip dysplasia, Beukes type.
1 publication has been identified in PubMed for hip dysplasia, Beukes type. Research spans Review / Meta-Analysis (100%).
Yan T (2025). [PMID: 40468360](https://pubmed.ncbi.nlm.nih.gov/40468360/). *Molecular neurodegeneration*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 7:14 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center